IL2 and Hyperglycemia: In overtly diabetic mice, IL-2 monotherapy was not sufficient for hyperglycemia reversal [70], however, IL-2 combined with sirolimus (rapamycin/RAPA) was even associated with a deleterious effect on pancreatic beta cells [18].